NCT02745860View on ClinicalTrials.gov

Comparison of Two Dose Strengths of Selexipag in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Healthy Subjects

Interventions

DRUG

Selexipag (adult formulation)

One selexipag film-coated tablet of 200 µg

DRUG

Selexipag (pediatric formulation)

Four selexipag film-coated tablets of 50 µg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Actelion

INDUSTRY